USFDA Warns of Heart Irritation After Novavax COVID Vaccine
Even though the company's analysis found it could reduce the likelihood of mild-to-severe disease, the US Food and Drug Administration has expressed concern about...
FDA Grants Novartis Cell Therapy For Follicular Lymphoma
The US Food and Drug Administration (FDA) has granted Novartis expedited approval for its CAR-T cell therapy Kymriah (tisagenlecleucel) to treat people with relapsed...
EMA guidance supports development of new antibiotics
As part of its efforts to support a global approach to the development of new antimicrobial medicines, EMA has published the final revised guideline...
Commercial Success In New Biopharmaceutical Innovation Era
AmerisourceBergen makes strategic investments, deploys solutions to raise its end-to-end suite of commercialization services, ushering in new monetization era.
The new era in biopharmaceutical development...
Proteros and AstraZeneca Boost Collaboration Agreement
Proteros biostructures GmbH, situated in Munich, has expanded its epigenetic medicine collaboration with AstraZeneca. This multi-year extension builds on a contract signed in June...
AbbVie and Cugene Join Forces Concerning Autoimmune Disorders and Cancer
AbbVie, located in Chicago, and Cugene, based in Waltham, Massachusetts, have formed a partnership to research medicines for autoimmune diseases and cancer. The arrangement...
Japan Pharma Lobby Says-Price Scheme Is Causing Drug Lag
For the first time in the week starting May 16th, Japan's three major pharmaceutical trade associations joined forces to call for changes to the...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...